LV PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LV PHARMA
Largest movements
- Receivables within one year +€44,446
up €44,446 (+276%), from €16,081 to €60,527
of which Other amounts receivable: +€60,496
- Reserves +€93,711
up €93,711 (+71.7%), from €130,753 to €224,464
- Debts after one year -€53,351
down €53,351 (-5.1%), from €1.0m to €995,876
- Gross operating margin +€56,400
up €56,400 (+44.8%), from €125,909 to €182,309
- Taxes +€14,841
up €14,841 (+64.3%), from €23,074 to €37,915
- Financial charges +€7,217
up €7,217 (+17.4%), from €41,410 to €48,627
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,392,611 | €1,442,617 | +€50,007 | +3.6% |
| Fixed assets | 21/28 | €1,330,559 | €1,328,762 | -€1,797 | -0.1% |
| Tangible fixed assets | 22/27 | €7,189 | €5,391 | -€1,797 | -25.0% |
| Plant, machinery and equipment | 23 | €655 | €383 | -€272 | -41.5% |
| Furniture and vehicles | 24 | €6,534 | €5,008 | -€1,525 | -23.3% |
| Financial fixed assets | 28 | €1,323,370 | €1,323,370 | = | 0.0% |
| Current assets | 29/58 | €62,052 | €113,856 | +€51,804 | +83.5% |
| Amounts receivable within one year | 40/41 | €16,081 | €60,527 | +€44,446 | +276% |
| Trade receivables | 40 | €16,050 | €0 | -€16,050 | -100% |
| Other amounts receivable | 41 | €31 | €60,527 | +€60,496 | +192,111% |
| Cash at bank and in hand | 54/58 | €44,086 | €50,523 | +€6,436 | +14.6% |
| Deferred charges and accrued income | 490/1 | €1,884 | €2,806 | +€922 | +48.9% |
| Total equity and liabilities | 10/49 | €1,392,611 | €1,442,617 | +€50,007 | +3.6% |
| Equity | 10/15 | €133,753 | €227,464 | +€93,711 | +70.1% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €130,753 | €224,464 | +€93,711 | +71.7% |
| Distributable reserves | 133 | €130,753 | €224,464 | +€93,711 | +71.7% |
| Amounts payable | 17/49 | €1,258,858 | €1,215,153 | -€43,704 | -3.5% |
| Amounts payable after more than one year | 17 | €1,049,227 | €995,876 | -€53,351 | -5.1% |
| Financial debts | 170/4 | €1,049,227 | €995,876 | -€53,351 | -5.1% |
| Amounts payable within one year | 42/48 | €201,121 | €201,595 | +€474 | +0.2% |
| Current portion of amounts payable after more than one year | 42 | €51,350 | €53,351 | +€2,002 | +3.9% |
| Trade debts | 44 | €759 | €839 | +€80 | +10.5% |
| Suppliers | 440/4 | €759 | €839 | +€80 | +10.5% |
| Taxes, remuneration and social security | 45 | €16,058 | €22,159 | +€6,101 | +38.0% |
| Taxes | 450/3 | €16,058 | €22,159 | +€6,101 | +38.0% |
| Other amounts payable | 47/48 | €132,954 | €125,246 | -€7,709 | -5.8% |
| Accrued charges and deferred income | 492/3 | €8,510 | €17,683 | +€9,173 | +108% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,364 | €1,797 | +€434 | +31.8% |
| Other operating charges | 640/8 | €256 | €261 | +€5 | +1.8% |
| Gross operating margin | 9900 | €125,909 | €182,309 | +€56,400 | +44.8% |
| Operating profit (loss) | 9901 | €124,290 | €180,251 | +€55,962 | +45.0% |
| Financial income | 75/76B | €1 | €1 | +€0 | +9.1% |
| Recurring financial income | 75 | €1 | €1 | +€0 | +9.1% |
| Financial charges | 65/66B | €41,410 | €48,627 | +€7,217 | +17.4% |
| Recurring financial charges | 65 | €41,410 | €48,627 | +€7,217 | +17.4% |
| Profit (loss) for the period before taxes | 9903 | €82,881 | €131,626 | +€48,745 | +58.8% |
| Income taxes | 67/77 | €23,074 | €37,915 | +€14,841 | +64.3% |
| Profit (loss) for the period | 9904 | €59,807 | €93,711 | +€33,904 | +56.7% |
| Profit (loss) for the period to be appropriated | 9905 | €59,807 | €93,711 | +€33,904 | +56.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.